BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
BioCryst Pharma has a consensus price target of $13.22.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $7.03 last updated November 15, 2024 at 4:33 PM EST.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.